|
|
|
This is the preliminary program for the 2009 Joint Statistical
Meetings in Washington, DC.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2009 Program page |
= Applied Session,
= Theme Session,
= Presenter
503
|
Wed, 8/5/09, 2:00 PM - 3:50 PM | CC-202A |
| Boundaries for Harm in Clinical Trials Designed to Establish Safety - Invited - Panel | ||
|
ENAR, Biopharmaceutical Section |
||
| Organizer(s): Robert A. Parker, Amgen, Inc. | ||
| Chair(s): Robert A. Parker, Amgen, Inc. | ||
| Abstract: | Boundaries for Harm in Clinical Trials Designed to Establish Safety | |
| Panelists: |
Alex Fleishman, Amgen, Inc. Barry Davis, The University of Texas School of Public Health Susan Ellenberg, University of Pennsylvania Gordon Lan, Johnson & Johnson PRD Michael Proschan, National Institute of Allergy and Infectious Diseases Janet Wittes, Statistics Collaborative, Inc.
|
|
| 3:45 PM | Floor Discussion | |
|
JSM 2009
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |